These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 579354)

  • 1. Blockade of para-methoxyamphetamine- induced serotonergic effects by chlorimipramine.
    Tseng LF; Harris RA; Loh NH
    J Pharmacol Exp Ther; 1978 Jan; 204(1):27-38. PubMed ID: 579354
    [No Abstract]   [Full Text] [Related]  

  • 2. Blockade of para-methoxyamphetamine induced serotonin release by serotonin uptake inhibitors.
    Tseng LF
    Proc West Pharmacol Soc; 1978; 21():7-9. PubMed ID: 308662
    [No Abstract]   [Full Text] [Related]  

  • 3. Importance of duration of drug action in the antagonism of p-chloroamphetamine depletion of brain serotonin-comparison of fluoxetine and chlorimipramine.
    Fuller RW; Snoddy HD; Perry KW; Bymaster FP; Wong DT
    Biochem Pharmacol; 1978 Jan; 27(2):193-8. PubMed ID: 623674
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological evidence for the central serotonergic effects of monomethoxyamphetamines.
    Menon MK; Tseng LF; Loh HH
    J Pharmacol Exp Ther; 1976 May; 197(2):272-9. PubMed ID: 946817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histochemical data on the reuptake blockade of monoamines by chlomipramine (author's transl)].
    Dumas ML; Pons F; Cadilhac J
    Ann Histochim; 1975; 20(4):283-90. PubMed ID: 1233916
    [No Abstract]   [Full Text] [Related]  

  • 6. Chlorimipramine inhibition of muricide: the role of the ascending 5-HT projection.
    Marks PC; O'Brien M; Paxinos G
    Brain Res; 1978 Jun; 149(1):270-3. PubMed ID: 566151
    [No Abstract]   [Full Text] [Related]  

  • 7. Antagonism of the acute and long-term biochemical effects of 4-chloroamphetamine on the 5-HT neurones in the rat brain by inhibitors of the 5-hydroxytryptamine uptake.
    Ross SB
    Acta Pharmacol Toxicol (Copenh); 1976; 39(4):456-76. PubMed ID: 989691
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of 2,5-dimethoxy-4-methylamphetamine (DOM) on operant behavior: interactions with other neuroactive agents.
    Commissaris RL; Semeyn DR; Moore KE; Rech RH
    Commun Psychopharmacol; 1980; 4(5):393-404. PubMed ID: 6120791
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of d-amphetamine, monomethoxyamphetamines and hallucinogens on schedule-controlled behavior.
    Harris RA; Snell D; Loh HH
    J Pharmacol Exp Ther; 1978 Jan; 204(1):103-17. PubMed ID: 619124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The increased release of 3H-5-hydroxytryptamine by d-para-methoxyamphetamine and d-amphetamine in vivo.
    Tseng LF
    Proc West Pharmacol Soc; 1976; 19():136-41. PubMed ID: 1036622
    [No Abstract]   [Full Text] [Related]  

  • 11. The stimulus properties of para-methoxyamphetamine: a nonessential serotonergic component.
    Winter JC
    Pharmacol Biochem Behav; 1984 Feb; 20(2):201-3. PubMed ID: 6546992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reinforcing and discriminative stimulus properties of para-ethoxy- and para-methoxyamphetamine.
    Corrigall WA; Robertson JM; Coen KM; Lodge BA
    Pharmacol Biochem Behav; 1992 Jan; 41(1):165-9. PubMed ID: 1539067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mazindol, fenfluramine and chlorimipramine on the 5-hydroxytryptamine uptake and storage mechanisms in rat brain: similarities and differences.
    Carruba MO; Picotti GB; Zambotti F; Mantegazza P
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Nov; 300(3):227-32. PubMed ID: 600310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analgesic and behavioral effects of amphetamine enantiomers, p-methoxyamphetamine and n-alkyl-p-methoxyamphetamine derivatives.
    Bustamante D; Díaz-Véliz G; Paeile C; Zapata-Torres G; Cassels BK
    Pharmacol Biochem Behav; 2004 Oct; 79(2):199-212. PubMed ID: 15501295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of nialamide-induced hypermotility in mice by lithium and the 5-HT uptake inhibitors chlorimipramine and FG 4963.
    Lassen JB; Squires RF
    Neuropharmacology; 1976 Nov; 15(11):665-8. PubMed ID: 137365
    [No Abstract]   [Full Text] [Related]  

  • 16. Uptake and release of 5-hydroxytryptamine by enteric 5-hydroxytryptaminergic neurones: effects of fluoxetine (Lilly 110140) and chlorimipramine.
    Gershon MD; Jonakait GM
    Br J Pharmacol; 1979 May; 66(1):7-9. PubMed ID: 313230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of tricyclic antidepressants on performance under a differential-reinforcement-of-low-rates schedule in rats.
    McGuire PS; Seiden LS
    J Pharmacol Exp Ther; 1980 Sep; 214(3):635-41. PubMed ID: 7400965
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydroxytryptamine uptake inhibitors block para- methoxyamphetamine-induced 5-HT release.
    Tseng LF
    Br J Pharmacol; 1979 Jun; 66(2):185-90. PubMed ID: 313827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of clomipramine and other inhibitors of monoamine uptake on the sexual behaviour of female rats and rhesus monkeys.
    Everitt BJ
    Postgrad Med J; 1977; 53 Suppl 4():202-10. PubMed ID: 414218
    [No Abstract]   [Full Text] [Related]  

  • 20. Withdrawal of the paradoxal sleep by the clomipramine, electrophysiological, histochemical and biochemical study.
    Passouant P; Cadhilac J; Billiard M
    Int J Neurol; 1975; 10(1-4):186-97. PubMed ID: 171234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.